Kimberly Popovits, President & CEO, Director at Genomic Health, holds 0.00 shares in Genomic Health (Ticker: GHDX), holds 2.30K shares in MyoKardia (Ticker: MYOK), holds ― shares in Kiniksa Pharmaceuticals (Ticker: KNSA).
Kimberly Popovits latest transaction was an Uninformative Sell of ―.
What was Kimberly Popovits's most profitable transaction?
Kimberly Popovits’s most profitable transaction was an Informative Buy of GHDX stock on March 16, 2018. The return on the trade was 125.20%.
What is Kimberly Popovits's role in Genomic Health?
Kimberly Popovits's role in Genomic Health is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.